Smiths Group plans £6 bn healthcare merger with ICU Medical
Category: #health  By Shikha Sinha  Date: 2018-05-28
  • share
  • Twitter
  • Facebook
  • LinkedIn

Smiths Group plans £6 bn healthcare merger with ICU Medical

British engineering business firm Smiths Group has reportedly opened talks with the U.S.-based ICU Medical Inc., over a potential GBP 6 billion deal to merge their medical device businesses. According to sources, the engineering giant has apparently held discussions about fusing its healthcare arm with a string of companies.

Reliable sources affirm that the Smiths Group has been for some time actively exploring options for its medical arm, Smiths Medical, that makes healthcare products such as mechanical ventilators and infusion pumps widely used in the hospitals. For the record, the business unit has also played a significant role in the successful surgical conception of the first test tube (IVF) baby.

According to latest reports, Smiths reported disappointing first-half profits in month of March for financial year 2018. The British engineering company’s largest medical devices unit was apparently hit by delays to launch new products into the market, while the revenues at the division dropped 5% to 451 million pounds (approximately USD 600.2 million) for the first six months of the year 2018.

If sources are to be believed, Smiths Medical has been the subject of M&As even before. A private equity group Apax had approached the parent company to buy the division for about GBP 2.45 billion, however the deal was declined in 2011. Reports reveal that since the past 10 years, Smiths has been the target for dismantling because of its pool of disparate businesses.

In a company statement, Smiths Group reported that they are still unsure of the transaction as it was at ‘very early stage’ discussion. Moreover, no financial details were revealed as there was no certainty that the deal would come to fruition.

Chief executive, Andrew Reynolds Smith has been reportedly spearheading the move and has revealed his strategy to build the company by focusing on divesting its smaller units that are not core. 



About Author

Shikha Sinha

Email: [email protected]   

Shikha Sinha

Shikha currently manages content operations for a series of news and business portals including MSF, Algosonline, and the like. An electrical & electronics engineer by education, she has prior experience in content & technology writing, content marketing, market resea...

Read More

More News By Shikha Sinha

Altimmune inks deal to acquire Spitfire Pharma and its NASH candidate
Altimmune inks deal to acquire Spitfire Pharma and its NASH candidate
By Shikha Sinha

Altimmune, Inc., a clinical stage biopharma company, has recently confirmed the closing of a formerly announced acquisition of Spitfire Pharma, Inc., including the strong GLP-1/Glucagon receptor co-agonist product cand...

NeurologyLive expands SAP program by partnering with Cleveland Clinic
NeurologyLive expands SAP program by partnering with Cleveland Clinic
By Shikha Sinha

NeurologyLive has reportedly added the Cleveland Clinic to its Strategic Alliance Partnership (SAP) program. Michael J. Hennessy Jr., President of NeurologyLive’s parent company MJH Associates Inc., said in a sta...

Neurocrine, Voyager reveal VY-AADC’s Phase I results at AAN 2019
Neurocrine, Voyager reveal VY-AADC’s Phase I results at AAN 2019
By Shikha Sinha

Neurocrine Biosciences Inc., along with Voyager Therapeutics Inc., has reportedly announced the Phase 1 results from the VY-AADC trial in eight patients suffering from Parkinson’s disease. Apparently, the patient...